We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALBT market cap is 3.72M. The company's latest EPS is USD -15.2684 and P/E is -0.22.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 331k | 322k | 315k | 327k | 346k |
| Operating Income | -1.48M | -10.26M | -950k | -1.4M | -1.27M |
| Net Income | -1.83M | -9.56M | -1.37M | -2.13M | -1.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.55M | 1.38M | 1.4M | 1.2M | 1.26M |
| Operating Income | -19.43M | -12.51M | -8.83M | -8.84M | -16.23M |
| Net Income | -18.07M | -12.68M | -9.09M | -11.93M | -16.71M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 29.97M | 20.58M | 20.33M | 19.52M | 19.55M |
| Total Liabilities | 13.14M | 13.21M | 14.28M | 15.1M | 14.15M |
| Total Equity | 16.82M | 7.37M | 6.05M | 4.42M | 5.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.49M | 10.37M | 10.24M | 19.75M | 20.58M |
| Total Liabilities | 6.03M | 6.25M | 7.16M | 8.59M | 13.21M |
| Total Equity | 4.47M | 4.12M | 3.09M | 11.16M | 7.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.71M | -6.51M | -916k | -2M | -3.89M |
| Investing | -22k | -22k | N/A | -100k | -100k |
| Financing | 4.09M | 4.83M | 936k | 2.01M | 4.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.08M | -7.55M | -5.03M | -7.04M | -6.51M |
| Investing | -552k | -169k | -68k | -9.05M | -22k |
| Financing | 6.16M | 7.67M | 5.17M | 17.26M | 4.83M |
| Market Cap | 3.72M |
| Price to Earnings Ratio | -0.22 |
| Price to Sales Ratio | 2.99 |
| Price to Cash Ratio | 13.17 |
| Price to Book Ratio | 0.51 |
| Dividend Yield | - |
| Shares Outstanding | 1.09M |
| Average Volume (1 week) | 122.16k |
| Average Volume (1 Month) | 2.68M |
| 52 Week Change | -50.72% |
| 52 Week High | 21.60 |
| 52 Week Low | 2.11 |
| Spread (Intraday) | 0.09 (2.58%) |
| Company Name | Avalon GloboCare Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.avalon-globocare.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
